11 results on '"4-OHT"'
Search Results
2. Control of CAR-T cells using destabilization domains
- Author
-
Belak, Monika and Benčina, Mojca
- Subjects
AR-T ,destabilizacijske domene ,destabilisation domains ,celična terapija ,4-OHT ,synthetic biology ,cell therapy ,sintezna biologija ,CAR-T - Abstract
Nadzor imunskih celic T, ki izražajo himerni antigenski receptor (CAR-T celice, angl. Chimeric Antigen Receptor T cells) z uporabo destabilizacijskih domen, je pomembno orodje za natančno in prilagodljivo regulacijo aktivnosti celic CAR-T. Destabilizacijske domene služijo kot varnostna stikala in omogočajo regulacijo aktivnosti celic CAR-T, preko modulacije stabilnosti himernega antigenskega receptorja (CAR) na površini celic z uporabo majhnih molekul. Z njihovo uporabo lahko omejimo stranske učinke in resne zaplete povezane s CAR-T celično terapijo, ki so predvsem posledica njihove prekomerne aktivacije. Do danes že poznamo nekaj nadzornih sistemov na osnovi destabilizacijskih domen (na primer destabilizacijski domeni ecDHFR ali FKBP). Ti sistemi imajo omejeno terapevtsko uporabnost, saj so njihovi ligandi molekule, ki so za človeške celice toksični, ali pa proteinske komponente teh sistemov izvirajo iz drugih organizmov in lahko izzovejo imunski odziv pri človeku. V sklopu magistrske naloge smo se tako osredotočili na razširitev trenutnega nabora destabilizacijskih domen. Uporabili smo destablizacijske domene na osnovi ligand vezavne domene estrogenskega receptorja alfa (ERα), ki se aktivirajo z molekulo 4-OHT, ki je FDA odobreno zdravilo. Pripravljene konstrukte smo vstavili v sesalske celične linije in preverili izražanje receptorja CAR po stimulaciji celic s tarčno majhno molekulo 4-OHT. Destabilizacijskim domenam, ki smo jim dodali CD19 CAR, je prisotnost liganda zagotovila stabilno izražanje receptorja na površini celic. Pričakujemo, da bodo načrtovane destabilizacijske domene pripomogle k razširitvi nabora hitrih, reverzibilnih in prilagodljivih metod za uravnavanje stabilnosti proteinov v živih celicah z uporabo majhnih molekul. The control of immune T cells expressing synthetic chimeric antigen receptors (CAR-T cells) using destabilization domains is an important tool for precise and adaptive regulation of CAR-T cell activity. Destabilization domains serve as safety switches and allow the regulation of CAR-T cell activity by modulating the stability of the CAR receptor on the cell surface using small molecules. Their use could limit the side effects and serious complications associated with CAR-T cell therapy, which are mainly due to their over-activation. To date, several control systems based on destabilization domains are known (e.g. ecDHFR or FKBP destabilization domains), but their number is limited. These systems have limited therapeutic utility because their ligands are molecules that are toxic to human cells, or the protein components of these systems are derived from other organisms and can elicit an immune response in humans. The focus of the MSc thesis was therefore to extend the current set of destabilization domains. We used destabilization domains based on the ligand binding domain of the estrogen receptor α (ERα), which are activated by the FDA approved drug, molecule 4-OHT. The prepared constructs were inserted into mammalian cell lines and the expression of the CAR receptor was verified after stimulation of the cells with the small target molecule 4-OHT. For the destabilization domains to which CD19 CAR was added, the presence of the ligand ensured stable expression of the receptor on the cell surface. We expect that the designed destabilization domains will help to extend the range of rapid, reversible and scalable methods to regulate protein stability in living cells using small molecules.
- Published
- 2023
3. Knockout of the PKN Family of Rho Effector Kinases Reveals a Non-redundant Role for PKN2 in Developmental Mesoderm Expansion
- Author
-
Ivan Quétier, Jacqueline J.T. Marshall, Bradley Spencer-Dene, Sylvie Lachmann, Adele Casamassima, Claudio Franco, Sarah Escuin, Joseph T. Worrall, Priththivika Baskaran, Vinothini Rajeeve, Michael Howell, Andrew J. Copp, Gordon Stamp, Ian Rosewell, Pedro Cutillas, Holger Gerhardt, Peter J. Parker, and Angus J.M. Cameron
- Subjects
PKC ,protein kinase C ,PKN ,Protein kinase N ,MEF ,mouse embryonic fibroblasts ,ES cells ,Embryonic stem cells ,4-OHT ,4-hydroxytamoxifen ,NCCs ,neural crest cells ,Biology (General) ,QH301-705.5 - Abstract
In animals, the protein kinase C (PKC) family has expanded into diversely regulated subgroups, including the Rho family-responsive PKN kinases. Here, we describe knockouts of all three mouse PKN isoforms and reveal that PKN2 loss results in lethality at embryonic day 10 (E10), with associated cardiovascular and morphogenetic defects. The cardiovascular phenotype was not recapitulated by conditional deletion of PKN2 in endothelial cells or the developing heart. In contrast, inducible systemic deletion of PKN2 after E7 provoked collapse of the embryonic mesoderm. Furthermore, mouse embryonic fibroblasts, which arise from the embryonic mesoderm, depend on PKN2 for proliferation and motility. These cellular defects are reflected in vivo as dependence on PKN2 for mesoderm proliferation and neural crest migration. We conclude that failure of the mesoderm to expand in the absence of PKN2 compromises cardiovascular integrity and development, resulting in lethality.
- Published
- 2016
- Full Text
- View/download PDF
4. Morphological changes in different caste adult ant specificities of Polyrhachis vicina Roger (Hymenoptera, Formicidae) caused in estrogen-related receptor.
- Author
-
Zhang, Juan-Juan and Xi, Geng-Si
- Subjects
- *
BIOCHANIN A , *ESTROGEN receptors , *POLYRHACHIS , *NUCLEAR receptors (Biochemistry) , *INSECT growth regulators - Abstract
The estrogen-related receptor (ERR) gene is a member of the nuclear receptor subfamily. Previous studies have indicated that ERR plays important roles in regulating insect growth and development. How ERR is associated with ant caste specificities remains unclear. In this study, we attempted to identify the role of ERR in the regulation of different adult caste specificities of Polyrhachis vicina Roger. Significant variations were detected in the ants including PvERR expressions, some physiological indexes and morphological traits including survival rate, body weight, body length, head width and abdominal appearance by different techniques. The results revealed that when PvERR expressions is up-regulated, boundaries of the abdominal segments were indistinct on the ventral side of the abdomen in males. Down-regulation of PvERR expressions caused abdominal swelling in males and a distended ventral abdomen in females and workers. Variation in PvERR expressions led to a remarkable decline in ant survival rates, particularly for males. These results indicated that different caste adults appeared to have different degrees of sensitivity in physiological response and morphological changes caused by variation in PvERR expressions. Thus, our data demonstrate that PvERR plays an important role in regulating the different adult caste specificities of P. vicina. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Knockout of the PKN Family of Rho Effector Kinases Reveals a Non-redundant Role for PKN2 in Developmental Mesoderm Expansion.
- Author
-
Quétier, Ivan, Marshall, Jacqueline J.T., Spencer-Dene, Bradley, Lachmann, Sylvie, Casamassima, Adele, Franco, Claudio, Escuin, Sarah, Worrall, Joseph T., Baskaran, Priththivika, Rajeeve, Vinothini, Howell, Michael, Copp, Andrew J., Stamp, Gordon, Rosewell, Ian, Cutillas, Pedro, Gerhardt, Holger, Parker, Peter J., and Cameron, Angus J.M.
- Abstract
Summary In animals, the protein kinase C (PKC) family has expanded into diversely regulated subgroups, including the Rho family-responsive PKN kinases. Here, we describe knockouts of all three mouse PKN isoforms and reveal that PKN2 loss results in lethality at embryonic day 10 (E10), with associated cardiovascular and morphogenetic defects. The cardiovascular phenotype was not recapitulated by conditional deletion of PKN2 in endothelial cells or the developing heart. In contrast, inducible systemic deletion of PKN2 after E7 provoked collapse of the embryonic mesoderm. Furthermore, mouse embryonic fibroblasts, which arise from the embryonic mesoderm, depend on PKN2 for proliferation and motility. These cellular defects are reflected in vivo as dependence on PKN2 for mesoderm proliferation and neural crest migration. We conclude that failure of the mesoderm to expand in the absence of PKN2 compromises cardiovascular integrity and development, resulting in lethality. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. Sex differences in cocaine-associated memory: The interplay between CB1, mGluR5, and estradiol.
- Author
-
Chang, Heng-Ai, Dai, Wen, and Hu, Sherry Shu-Jung
- Subjects
- *
CELLULAR signal transduction , *COCAINE abuse , *ESTRADIOL benzoate , *REWARD (Psychology) , *ESTRADIOL , *DRUG-seeking behavior - Abstract
We know surprisingly little about the sex differences in the neurobiology of cocaine addiction, except females are more susceptible to the rewarding effects of cocaine than their male counterparts. Only a handful of recent studies have examined the neurobiology of cocaine-induced conditioned place preference (CPP) memory among female rodents. We contribute to this emerging line of research by documenting sex differences in cocaine-associated memory and illustrating the underlying signaling pathways in five experiments. Rimonabant (Rim), a cannabinoid CB 1 antagonist and inverse agonist, exerted a facilitating effect for low-dose cocaine and an impairing effect for high-dose cocaine CPP memory in male mice, as in our previous study, but not in female mice. Nor did we observe the effect exist among CB 1 knockout male mice, which indicated that the CB 1 receptors played a mediating role. We also found that the metabotropic glutamate receptor 5 (mGluR5) was located in the same signaling pathway as CB 1 in male mice. To clarify the mechanisms behind the sex differences, we used ovariectomized (OVX) female mice with estradiol benzoate (EB) replacement. In the OVX female mice, we showed that Rim-alone and EB-alone, but not Rim-and-EB-combined, facilitated the low-dose cocaine CPP memory. Moreover, 4-hydroxytamoxifen (4-OHT), an estrogen receptor (ER) antagonist, blocked Rim's and EB's facilitating effect. Finally, 2-methyl-6-(phenylethynyl)pyridine (MPEP), an mGluR5 antagonist, partially blocked EB's facilitating effect. In sum, we identified sex-specific effects of Rim on cocaine-induced CPP memory and the respective signaling pathways: mGluR5-CB 1 for male mice and ER-mGluR5-CB 1 for female mice. These findings may have merits for the development of sex-specific treatment for cocaine addiction. ● Females are more susceptible to the rewarding effects of cocaine than their male counterparts. ● However, we know surprisingly little about the sex differences in the neurobiology of cocaine addiction, and only a handful of recent studies have examined the neurobiology of cocaine-induced conditioned place preference (CPP) memory among female rodents. ● We contribute to this emerging line of research by documenting sex differences in cocaine-induced CPP memory and illustrating the underlying signaling pathways. ● We identified sex-specific effects of rimonabant (Rim), a cannabinoid CB 1 antagonist and inverse agonist, on cocaine-induced CPP memory and the respective signaling pathways involving metabotropic glutamate receptor 5 (mGluR5) and estrogen receptor (ER): mGluR5-CB 1 for male mice and ER-mGluR5-CB 1 for female mice. ● We believe this novel discovery of Rim's sex-specific signaling pathways in cocaine-associated memory may have implications for the development of sex-specific treatment for cocaine addiction. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. The kinetics of ER fusion protein activation in vivo
- Author
-
Trevor D. Littlewood, Jeremy Auw, Ivonne Gamper, Catherine H. Wilson, Alessandra Perfetto, Gerard I. Evan, Wilson, Catherine [0000-0002-5333-0295], Littlewood, Trevor [0000-0003-3475-1462], Evan, Gerard [0000-0003-0412-1216], and Apollo - University of Cambridge Repository
- Subjects
Transcriptional Activation ,Cancer Research ,Recombinant Fusion Proteins ,medicine.medical_treatment ,Intraperitoneal injection ,Kinetics ,Administration, Oral ,Antineoplastic Agents ,Biology ,Pharmacology ,Article ,Islets of Langerhans ,Mice ,Genes, Reporter ,In vivo ,Genetics ,medicine ,Animals ,skin and connective tissue diseases ,Receptor ,Molecular Biology ,Gene ,ERTAM ,Fusion protein ,In vitro ,Rats ,3. Good health ,Cell biology ,Tamoxifen ,ER ,Receptors, Estrogen ,4-OHT ,Tumor Suppressor Protein p53 ,Injections, Intraperitoneal ,hormones, hormone substitutes, and hormone antagonists ,estrogen receptor ,medicine.drug - Abstract
Reversibly switchable proteins are powerful tools with which to explore protein function in vitro and in vivo. For example, the activity of many proteins fused to the hormone-binding domain of the modified oestrogen receptor (ER(TAM)) can be regulated by provision or removal of 4-hydroxytamoxifen (4-OHT). Despite the widespread use of ER(TAM) fusions in vivo, inadequate data are available as to the most efficacious routes for systemic tamoxifen delivery. In this study, we have used two well-characterized ER(TAM) fusion proteins, both reversibly activated by 4-OHT, to compare the effectiveness and kinetics of 4-OHT delivery in mice in vivo by either tamoxifen in food or by intraperitoneal injection. Our data indicate that dietary tamoxifen offers an effective, facile and ethically preferable means for long-term activation of ER(TAM) fusion proteins in vivo.
- Published
- 2014
- Full Text
- View/download PDF
8. Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance
- Author
-
Pitta, Chara A., Papageorgis, P., Charalambous, Christina, Constantinou, Andreas I., and Constantinou, Andreas I. [0000-0003-0365-1821]
- Subjects
MTT ,Cancer Research ,Time Factors ,DNMT ,Estrogen receptor ,5-AZA ,Apoptosis ,Estrogen receptors ,hydroxytamoxifen ,trichostatin A ,Hydroxamic Acids ,Breast cancer ,E2 ,HDAC ,cancer resistance ,skin and connective tissue diseases ,TSA ,article ,apoptosis ,Tamoxifen resistance ,Transfection ,3-(4,5-dimethylthiazol-2-yl)-2,5-monotetrazolium bromide ,4-hydroxytamoxifen ,Chromatin ,Gene Expression Regulation, Neoplastic ,chemosensitivity ,priority journal ,Oncology ,cell cycle arrest ,Selective estrogen receptor modulator ,Azacitidine ,MCF-7 Cells ,protein transport ,Epigenetics ,Female ,DNA methyl transferases ,SERMs ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug ,Antineoplastic Agents, Hormonal ,Cell Survival ,Active Transport, Cell Nucleus ,Breast Neoplasms ,17β estradiol ,Biology ,Decitabine ,medicine ,Estrogen Receptor beta ,Humans ,Gene silencing ,controlled study ,Gene Silencing ,Viability assay ,protein expression ,expression vector ,cell viability ,estrogen receptor beta ,5-2′-deoxycytidine ,Dose-Response Relationship, Drug ,protein p21 ,protein pS2 ,5 aza 2' deoxycytidine ,estrogen receptor β ,ER-α ,ER-β ,estrogen receptor α ,Chromatin Assembly and Disassembly ,Molecular biology ,Histone Deacetylase Inhibitors ,cell strain MCF 7 ,Tamoxifen ,E(2) ,Trichostatin A ,selective estrogen receptor modulators ,Drug Resistance, Neoplasm ,histone deacetylase ,Cancer research ,4-OHT - Abstract
The purpose of this work is to determine the molecular mechanisms underlying tamoxifen resistance. We show here that ER-β is epigenetically silenced in a cell line with acquired tamoxifen resistance (MCF-7/TAM-R) and this could be reversed by 5-AZA-deoxycytidine (5-AZA) and trichostatin-A (TSA) pre-treatment. Subsequent treatment with 4-hydroxy-tamoxifen (4-OHT) induced ER-β nuclear translocation, upregulated pS2 and p21 levels and reduced cell viability. Transfection with an ER-β expression vector sensitized MCF-7/TAM-R cells to the growth inhibitory and pro-apoptotic effects of 4-OHT, indicating that ER-β re-expression alone is sufficient to restore sensitivity to tamoxifen. This novel finding reveals that ER-β is fundamental in overcoming acquired tamoxifen resistance and provides insights for new therapeutic protocols against breast cancer. © 2013 Elsevier Ireland Ltd. 337 167 176 Manufacturers: Alexis, Switzerland Cited By :9
- Published
- 2013
- Full Text
- View/download PDF
9. Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro
- Author
-
Rudolph, Bettina, Hueber, Anne-Odile, and Evan, Gerard I
- Published
- 2000
- Full Text
- View/download PDF
10. Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
- Author
-
David Vindrieux, Delphine Gitenay, Clotilde Wiel, Hélène Simonnet, H Lallet-Daher, Sébastien Aubert, David Bernard, Léa Payen, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Léon Bérard [Lyon], Université de Lyon, Institut de Pathologie [CHU Lille], Pôle de Biologie Pathologie Génétique [CHU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut pour la Recherche sur le Cancer de Lille (U837 INSERM - IRCL), Institut pour la recherche sur le cancer de Lille [Lille] (IRCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospices Civils de Lyon (HCL), We thank M Ferrand, M Samyn, M Manchon, and D Collin Chavagnac for help and materials, and other laboratory members for helpful suggestions and discussions. This work was carried out with the support of the ‘Fondation de France’, the ‘Comités de l’Ardèche et de la Drome de la Ligue nationale contre le Cancer’, the ‘Institut National du Cancer’, and the ‘RTRS Fondation Synergie Lyon Cancer’. CW is supported by the ‘Ligue contre le Cancer’ and the ‘Fondation pour la Recherche Médicale’., Hennaut, Odile, Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Institut pour la recherche sur le cancer de Lille [Lille] (IRCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre de Recherche Jean-Pierre AUBERT - Neurosciences et Cancer -JPArc [Lille]
- Subjects
Cancer Research ,Time Factors ,HK2 ,Glucose uptake ,senescence-associated b-galactosidase ,glucose-6-phosphate OIS ,chemistry.chemical_compound ,0302 clinical medicine ,Hexokinase ,[CHIM] Chemical Sciences ,Glycolysis ,hexokinase-2 ,Enzyme Inhibitors ,Cells, Cultured ,Cellular Senescence ,metabolites ,0303 health sciences ,oncogene-induced senescence ,4-hydroxytamoxifen ,Biochemistry ,Female ,Original Article ,Corrigendum ,Cell aging ,2-deoxy-D-glucose ,PPP ,glucose metabolism ,adenosine triphosphate ,Immunology ,pentose phosphate pathway ,Glucose-6-Phosphate ,Carbohydrate metabolism ,Pentose phosphate pathway ,Biology ,Transfection ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Humans ,[CHIM]Chemical Sciences ,Mammary Glands, Human ,G6P ,metabolites Abbreviations: 2DG ,030304 developmental biology ,Epithelial Cells ,Hexosamines ,Oncogenes ,Metabolism ,Cell Biology ,ATP ,Kinetics ,Glucose ,chemistry ,Glucose 6-phosphate ,4-OHT ,Energy Metabolism ,SA-b-Gal ,030217 neurology & neurosurgery - Abstract
A Corrigendum to this article was published on 14 August 2014 6 DOI / 10.1038/cddis.2014.360Since the publication of this paper the authors have noticed an error in the abstract section. ‘Inversely, expressing a G6P,pharmacological inhibition of HK2,’ is replaced by ‘Inversely, expressing a glucose-6-phosphatase, pharmacological inhibition of HK2,’.The corrected article appears online together with this corrigendum.The authors would like to apologize for any inconvenience caused.; International audience; Oncogenic stress-induced senescence (OIS) prevents the ability of oncogenic signals to induce tumorigenesis. It is now largely admitted that the mitogenic effect of oncogenes requires metabolic adaptations to respond to new energetic and bio constituent needs. Yet, whether glucose metabolism affects OIS response is largely unknown. This is largely because of the fact that most of the OIS cellular models are cultivated in glucose excess. In this study, we used human epithelial cells, cultivated without glucose excess, to study alteration and functional role of glucose metabolism during OIS. We report a slowdown of glucose uptake and metabolism during OIS. Increasing glucose metabolism by expressing hexokinase2 (HK2), which converts glucose to glucose-6phosphate (G6P), favors escape from OIS. Inversely, expressing a glucose-6-phosphatase, pharmacological inhibition of HK2, or adding nonmetabolizable glucose induced a premature senescence. Manipulations of various metabolites covering G6P downstream pathways (hexosamine, glycolysis, and pentose phosphate pathways) suggest an unexpected role of the hexosamine pathway in controlling OIS. Altogether, our results show that decreased glucose metabolism occurs during and participates to OIS.
- Published
- 2014
- Full Text
- View/download PDF
11. COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.
- Author
-
Litchfield LM, Appana SN, Datta S, and Klinge CM
- Subjects
- Breast Neoplasms genetics, DNA, Neoplasm metabolism, Drug Resistance, Neoplasm genetics, Female, Gene Expression Regulation, Neoplastic drug effects, Humans, Imidazoles pharmacology, MCF-7 Cells, Phosphorylation drug effects, Protein Binding drug effects, Protein Binding genetics, Protein Subunits genetics, Protein Subunits metabolism, Quinoxalines pharmacology, RNA, Messenger genetics, RNA, Messenger metabolism, Signal Transduction drug effects, Signal Transduction genetics, Transcription Factor RelA metabolism, Breast Neoplasms metabolism, COUP Transcription Factor II metabolism, Drug Resistance, Neoplasm drug effects, Hormones pharmacology, NF-kappa B metabolism
- Abstract
Reduced COUP-TFII expression contributes to endocrine resistance in breast cancer cells. Endocrine-resistant breast cancer cells have higher NFkappa B (NFκB) activity and target gene expression. The goal of this study was to determine if COUP-TFII modulates NFκB activity. Endocrine-resistant LCC9 cells with low endogenous COUP-TFII displayed ∼5-fold higher basal NFκB activity than parental endocrine-sensitive MCF-7 breast cancer cells. Transient transfection of LCC9 cells with COUP-TFII inhibited NFκB activation and reduced NFκB target gene expression. COUP-TFII and NFκB were inversely correlated in breast cancer patient samples. Endogenous COUP-TFII coimmunoprecipitated with NFκB subunits RelB and NFκB1 in MCF-7 cells. COUP-TFII inhibited NFκB-DNA binding in vitro and impaired coactivator induced NFκB transactivation. LCC9 cells were growth-inhibited by an NFκB inhibitor and 4-hydroxytamoxifen compared to MCF-7 cells. Together these data indicate a novel role for COUP-TFII in suppression of NFκB activity and explain, in part, why decreased COUP-TFII expression results in an endocrine-resistant phenotype., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.